Skip to main content
. 2019 Nov;6(11):935–950. doi: 10.1016/S2215-0366(19)30331-1

Table 4.

Negative binomial regression of patients estimated to have been receiving an antidepressant, opioid, gabapentinoid, benzodiazepine, or Z-drug for at least 12 months, adjusted by sex, age, and deprivation category

Unadjusted IRR Adjusted IRR E-value*
Antidepressants (N=4 482 793)
Sex
Male 1·00 (ref) 1·00 (ref) ..
Female 1·01 (1·00–1·01) 1·00 (1·00–1·01) 1·07 (1·02)
Age, years
18–24 1·00 (ref) 1·00 (ref) ..
25–44 1·71 (1·68–1·75) 1·70 (1·67–1·73) 2·79 (2·72)
45–64 2·28 (2·23–2·34) 2·27 (2·21–2·32) 3·96 (3·85)
65–74 2·60 (2·54–2·67) 2·61 (2·54–2·67) 4·65 (4·52)
≥75 2·72 (2·64–2·79) 2·74 (2·66–2·82) 4·93 (4·77)
IMD quintile
1 (least deprived) 1·00 (ref) 1·00 (ref) ..
2 1·05 (1·02–1·08) 1·06 (1·03–1·10) 1·32 (1·20)
3 1·05 (1·02–1·09) 1·07 (1·03–1·11) 1·35 (1·22)
4 1·10 (1·06–1·14) 1·13 (1·08–1·17) 1·50 (1·39)
5 (most deprived) 1·15 (1·11–1·20) 1·19 (1·14–1·25) 1·68 (1·55)
Model constant .. 0·22 (0·21–0·23) ..
Opioids (N=2 345 796)
Sex
Male 1·00 (ref) 1·00 (ref) ..
Female 1·03 (1·03–1·04) 1·05 (1·04–1·05) 1·27 (1·25)
Age, years
18–24 1·00 (ref) 1·00 (ref) ..
25–44 2·45 (2·36–2·53) 2·45 (2·37–2·54) 4·34 (4·17)
45–64 2·99 (2·87–3·11) 3·02 (2·90–3·15) 5·49 (5·25)
65–74 3·01 (2·89–3·14) 3·07 (2·94–3·21) 5·60 (5·33)
≥75 2·88 (2·75–3·00) 2·95 (2·83–3·08) 5·35 (5·10)
IMD quintile
1 (least deprived) 1·00 (ref) 1·00 (ref) ..
2 1·06 (1·04–1·07) 1·06 (1·04–1·07) 1·31 (1·25)
3 1·09 (1·06–1·12) 1·09 (1·07–1·12) 1·41 (1·34)
4 1·14 (1·10–1·17) 1·14 (1·11–1·18) 1·55 (1·47)
5 (most deprived) 1·15 (1·11–1·19) 1·17 (1·13–1·21) 1·61 (1·50)
Model constant .. 0·15 (0·15–0·16) ..
Gabapentinoids (N=855 680)
Sex
Male 1·00 (ref) 1·00 (ref) ..
Female 0·97 (0·96–0·97) 0·97 (0·97–0·98) 1·19 (1·18)
Age, years
18–24 1·00 (ref) 1·00 (ref) ..
25–44 1·54 (1·49–1·60) 1·50 (1·44–1·56) 2·37 (2·25)
45–64 1·72 (1·66–1·79) 1·68 (1·62–1·74) 2·75 (2·62)
65–74 1·70 (1·64–1·76) 1·68 (1·63–1·74) 2·76 (2·64)
≥75 1·71 (1·66–1·77) 1·72 (1·66–1·79) 2·84 (2·71)
IMD quintile
1 (least deprived) 1·00 (ref) 1·00 (ref) ..
2 1·07 (1·04–1·10) 1·08 (1·05–1·10) 1·36 (1·27)
3 1·09 (1·05–1·12) 1·09 (1·06–1·13) 1·41 (1·31)
4 1·14 (1·11–1·18) 1·15 (1·11–1·18) 1·56 (1·47)
5 (most deprived) 1·19 (1·14–1·24) 1·20 (1·15–1·25) 1·68 (1·56)
Model constant .. 0·30 (0·29–0·31) ..
Benzodiazepines (N=419 903)
Sex
Male 1·00 (ref) 1·00 (ref) ..
Female 1·03 (1·02–1·04) 1·00 (0·98–1·01) 1·05 (1·00)
Age, years
18–24 1·00 (ref) 1·00 (ref) ..
25–44 2·85 (2·62–3·10) 2·80 (2·58–3·04) 5·05 (4·60)
45–64 3·98 (3·63–4·38) 3·90 (3·55–4·27) 7·26 (6·57)
65–74 4·46 (4·05–4·92) 4·47 (4·05–4·92) 8·40 (7·57)
≥75 4·54 (4·12–5·01) 4·65 (4·21–5·13) 8·76 (7·89)
IMD quintile
1 (least deprived) 1·00 (ref) 1·00 (ref) ..
2 1·10 (1·08–1·13) 1·12 (1·09–1·15) 1·49 (1·42)
3 1·15 (1·11–1·19) 1·18 (1·13–1·22) 1·63 (1·52)
4 1·24 (1·20–1·28) 1·28 (1·24–1·32) 1·89 (1·79)
5 (most deprived) 1·30 (1·24–1·36) 1·37 (1·31–1·43) 2·08 (1·95)
Model constant .. 0·11 (0·10–0·12) ..
Z-drugs (N=364 617)
Sex
Male 1·00 (ref) 1·00 (ref) ..
Female 1·05 (1·04–1·06) 1·05 (1·04–1·06) 1·27 (1·23)
Age, years
18–24 1·00 (ref) 1·00 (ref) ..
25–44 4·10 (3·60–4·66) 4·03 (3·55–4·58) 7·52 (6·55)
45–64 5·62 (4·90–6·44) 5·61 (4·90–6·44) 10·71 (9·26)
65–74 6·01 (5·24–6·90) 6·20 (5·39–7·13) 11·88 (10·26)
≥75 6·08 (5·29–6·98) 6·37 (5·53–7·34) 12·22 (10·53)
IMD quintile
1 (least deprived) 1·00 (ref) 1·00 (ref) ..
2 1·05 (1·02–1·09) 1·07 (1·04–1·11) 1·35 (1·25)
3 1·11 (1·06–1·16) 1·15 (1·09–1·21) 1·56 (1·40)
4 1·15 (1·10–1·20) 1·22 (1·17–1·27) 1·74 (1·62)
5 (most deprived) 1·16 (1·11–1·21) 1·27 (1·21–1·32) 1·85 (1·72)
Model constant .. 0·08 (0·07–0·10) ..

IRR=incident rate ratio.

*

Lower bound of the CI towards the null.